Showing 1 - 10 of 52
The end of 2019 saw the emergence of a novel severe acute respiratory syndrome: coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). As of December 2023, eight vaccines (Comirnaty, Spikevax, Vaxzevria, Jcovden Valneva, Nuvaxovid, VidPrevtyn, and Bimervax) have been...
Persistent link: https://www.econbiz.de/10015278093
This protocol presents a common updated methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating European Union and European Economic Area (EU/EEA) countries. This work is performed within the Vaccine Effectiveness, Burden and...
Persistent link: https://www.econbiz.de/10015278065
This protocol presents a common methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating EU/EEA Member States. This work is performed within the Vaccine Effectiveness, Burden and Impact Studies (VEBIS) framework contract. A pilot...
Persistent link: https://www.econbiz.de/10015280556
The end of 2019 saw the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). By early August 2022, over 160 million cases and over one million deaths had been reported in the European Union/European Economic Area...
Persistent link: https://www.econbiz.de/10015280798
This protocol describes the common methodology to be applied to established health data registries across seven participating European Union/European Economic Area (EU/EEA) Member States to estimate vaccine effectiveness for Coronavirus disease 2019 (COVID-19) in children and adolescents aged...
Persistent link: https://www.econbiz.de/10015277812
Persistent link: https://www.econbiz.de/10003688599
Persistent link: https://www.econbiz.de/10003688601
Compared with the general public, people in prison in the EU/EEA have a higher burden of communicable diseases such as human immunodeficiency virus (HIV), hepatitis B, hepatitis C, syphilis, gonorrhoea, chlamydia and tuberculosis (TB). Increased disease prevalence in this population is...
Persistent link: https://www.econbiz.de/10015285970
Persistent link: https://www.econbiz.de/10015289142
ECDC has been working with EU Candidate Countries since 2006 and with EU Potential Candidate Countries since 2009 to prepare them for participation in ECDC activities. Work with these countries has been mainly financed by a Contribution Agreement between the Directorate-General for Neighbourhood...
Persistent link: https://www.econbiz.de/10015294394